Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
A lock-up agreement restricting iBio insiders from selling 19.7 million shares expires on Nov. 18, 2025, allowing unrestricted trading.
A lock-up agreement restricting iBio, Inc. executives and directors from selling 19.7 million shares and related securities expires on November 18, 2025.
The 90- to 91-day restriction, which began August 19, 2025, required prior consent from Leerink Partners LLC, acting as underwriter representative, to prevent market volatility after a public offering.
The agreement applied to specific stock options, restricted stock units, and warrants held by insiders.
Upon expiration, these insiders may freely trade their shares under normal securities regulations.
5 Articles
Un acuerdo de bloqueo que restringe a los insiders de iBio de vender 19.7 millones de acciones expira el 18 de noviembre de 2025, permitiendo el comercio sin restricciones.